A surgical approach to a cricothyrotomy that helps to maintain control during a high-stress situation. This quick and controlled cricothyrotomy has been created to perform a blind cricothyrotomy in under 2 minutes, and is packaged to simplify the procedure.
Control-Cric™ Emergency Cricothyrotomy
A surgical approach to a cricothyrotomy that helps to maintain control during a high-stress situation. This quick and controlled cricothyrotomy has been created to perform a blind cricothyrotomy in under 2 minutes, and is packaged to simplify the procedure.
Related products
-
3M™ Ranger™ Blood/Fluid Warming Unit, 24500, 120V-ENG-B
Read moreCompact space-saving design Large, easy-to-read temperature display Audible/visible, over/under temperature alarm indicators Convenient over-temperature test function
-
C-PAP Bousignac
Read moreRespiratory assist device for spontaneously ventilating patients. This device allows to maintain a higher pressure in the airways than atmospheric pressure throughout the respiratory cycle. The CPAP ventilation mode allows: – Recruit collapsed alveoli; – Restore a satisfactory level of functional residual capacity; – Improve the exchange of gases at the level of the capillary alveolus membrane – Decrease pulmonary resistance; – Reduce the effort to breathe; – Redistribute the alveolar fluid to the interstitial space in case of acute pulmonary edema The Boussignac CPAP device and its connector for manometer constitute a device that is connects to a face mask via a 22mm male connector, ribbed top open to air
-
i Stat Alinity
Read moreThe i‑STAT Alinity is an easy-to-use, portable blood analyser that delivers real-time, lab-quality diagnostic test results at the point-of-care. Built on the proven technology of the i‑STAT 1 System, the i‑STAT Alinity’s award-winning design features a more intuitive interface that simplifies the testing process even further, allowing for minimal operator training. i‑STAT Alinity is the i‑STAT family’s most advanced testing solution.













Reviews
There are no reviews yet.